Public Health Trace

Get Alerts

Data Explorer

Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.

Recall totals

All FDA and USDA recalls in Public Health Trace, June 2012 to October 2026.

37,326

Total recall recordsAll FDA and USDA recalls in Public Health Trace

9,859

Class I recallsReasonable probability of serious health consequences

24,440

Class II recallsTemporary or medically reversible health consequences

2,900

Class III recallsNot likely to cause adverse health consequences

Quick insights

A snapshot of the most notable patterns across all recorded FDA and USDA recalls.

Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap. 53 recalls

Most common hazardLack of Assurance of Sterility 2,095 recalls

Newest recallhttp://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/winco-foods-llc-issues-allergy-alert-undeclared-sesame-hoagie-rollsPublished October 22, 2026

Most affected stateHawaii 200 recalls mention this state

State: LA ×
Clear all

Download matching recalls as CSV

CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.

Filters

Timeline Classification Table

Metric

Time range

Group by

View

Recalls announced by month (Year to date)

Download CSV

Source: FDA and USDA public dataLast updated October 24, 2026 ET

Summary (Year to date)

1,739 recalls have been announced year to date.
Sep 2026 was 15% higher than the previous complete period (Aug 2026: 182).
The highest complete period was Jun 2026 (300).
Oct 2026 is incomplete and not included in the figures above.

Complete data
Incomplete

Recalls by class

Recalls by class
Class	Recalls
Class II	24,440
Class I	9,859
Class III	2,900
Not Yet Classified	2

Recalls by class
Class	Recalls
Class II	24,440
Class I	9,859
Class III	2,900
Not Yet Classified	2

FDA Recall TerminatedTerminated: June 7, 2023Historical recordClass II

Phenol, Topical Solution (PF) Multiple Dose Vial, 89%, 3 mL per vial, Edge Pharma, LLC, 856 Hercules Dr., Colchester, VT, NDC 05446-1211-03

by Edge Pharma, LLC

Reason: CGMP Deviations
Published: February 2, 2022
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: June 7, 2023Historical recordClass II

Profound-PE Dental Gel, Lidocaine HCl/Prilocaine HCl/Tetracaine HCl/Phenylephrine, 10% / 10% / 4% / 2%, Spear-Peppermint, Multiple Dose Container for Topical Oral Use, 30 grams per jar, Edge Pharma, LLC, 856 Hercules Dr., Colchester, VT, 05446, NDC 05446-0408-10

by Edge Pharma, LLC

Reason: CGMP Deviations
Published: February 2, 2022
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: June 7, 2023Historical recordClass II

Profound-PE Dental Gel, Lidocaine HCl/ Prilocaine HCl/ Tetracaine HCl/ Phenylephrin HCl, 10% / 10% / 4% / 2% Raspberry-Marshmallow, Multiple Dose Container for Topical Oral Use, Edge Pharma, LLC, 856 Hercules Dr. Colchester, VT NDC 05446-1018-10

by Edge Pharma, LLC

Reason: CGMP Deviations
Published: February 2, 2022
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: June 7, 2023Historical recordClass II

Profound Dental Gel, Lidocaine HCl/Prilocaine HCl/Tetracaine HCl, 10% / 10% / 4%, Spearmint-Peppermint, Multiple Dose Container for Topical Oral Use, Edge Pharma, LLC, 856 Hercules Dr. Colchester, VT NDC 05446-0407-10

by Edge Pharma, LLC

Reason: CGMP Deviations
Published: February 2, 2022
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: June 7, 2023Historical recordClass II

Profound Dental Gel, Lidocaine HCl/Prilocaine HCl/Tetracaine HCl, 10%/10%/4% Raspberry Marshmallow, 30 grams per jar, Multiple Dose Container For Topical Oral Use,Edge Pharma LLC, 856 Hercules Dr. Colchester, VT 05446, NDC 05446-0790-10

by Edge Pharma, LLC

Reason: CGMP Deviations
Published: February 2, 2022
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: June 7, 2023Historical recordClass II

Lidocaine HCl / Oxymetazoline HCl Nasal Solution, 4% / 0.05%, 240mL per bottle, Multiple Dose Container for Intranasal Use, Edge Pharma, LLC, 856 Hercules Dr., Colchester, VT 05446, NDC 05446-1256-01, packaged in bottles. no label

by Edge Pharma, LLC

Reason: CGMP Deviations
Published: February 2, 2022
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: June 7, 2023Historical recordClass II

LET Topical Gel, Lidocaine HCL / Epinepherine / Tetracaine HCl, 4%/0.05%/0.5%, 3 mL per syringe, Single Dose Syringe for Topical Use, Edge Pharma, LLC, 856 Hercules Dr. Colchester, VT, NDC 05446-0607-01

by Edge Pharma, LLC

Reason: CGMP Deviations
Published: February 2, 2022
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: June 7, 2023Historical recordClass II

LT Topical Cream, Lidocaine/Tetracaine, 23%/7%, 60gm per jar, Multiple Dose Container for Topical Use, Edge Pharma, LLC, 856 Hercules, VT, Colchester, VT 05446, NDC 05446-1647-01

by Edge Pharma, LLC

Reason: CGMP Deviations
Published: February 2, 2022
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: June 7, 2023Historical recordClass II

Dibutyl Squaric Acid, Topical Solution (PF) Multiple Dose Vial, 1%, 10 mL per vial, Edge Parma, LLC, 856 Hercules Dr., Colchester, VT 05446, NDC 05446-1156-03

by Edge Pharma, LLC

Reason: CGMP Deviations
Published: February 2, 2022
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: June 7, 2023Historical recordClass II

Dibutyl Squaric Acid, Topical Solution (PF), Multiple Dose Vial, 2%, 10 mL per vial, Edge Pharma, LLC, 856 Hercules Dr, Colchester VT, 05446, NDC 05446-1047-03

by Edge Pharma, LLC

Reason: CGMP Deviations
Published: February 2, 2022
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: June 7, 2023Historical recordClass II

Dexamethasone sodium phosphate 0.4%, 120 mL per bottle, Multiple Dose Container For Topical Use, Edge Pharma, LLC, 856 Hercules Dr., Colchester, VT 05446, NDC 05446-0622-01

by Edge Pharma, LLC

Reason: CGMP Deviations
Published: February 2, 2022
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: June 7, 2023Historical recordClass II

CSF-HC Otic Insufflation Capsule, Sulfacetamide Sodium/Ciprofloxacin/Hydrocortisone/Amphotericin B Otic Powder, 50mg/ 30mg/ 25mg/ 5mg, 5 count bottle, Edge Pharma, LLC, 856 Hercules Dr., Colchester, VT 05446, NDC 05446-1634-01

by Edge Pharma, LLC

Reason: CGMP Deviations
Published: February 2, 2022
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: June 7, 2023Historical recordClass II

CSF Otic Insufflation Capsule, Sulfacetamide Sodium/ Ciprofloxacin/ Amphotericin B Otic Powder, 50mg / 30mg / 5mg, 5 count bottle, For Otic Use with Insufflator, Edge Pharma, LLC 856 Hercules Dr., Colchester, VT 05446, NDC 05446-1633-05

by Edge Pharma, LLC

Reason: CGMP Deviations
Published: February 2, 2022
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: June 7, 2023Historical recordClass II

Cantharidin PLUS, Cantharidin/Salicylic Acid Gel-Forming Suspension, 10 mL per vial, Multiple Dose Vials for Topical Use, Edge Pharma, LLC, 856 Hercules Dr., Colchester, VT, 05446, NDC 05446-0970-03

by Edge Pharma, LLC

Reason: CGMP Deviations
Published: February 2, 2022
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: June 7, 2023Historical recordClass II

Cantharidin Gel-Forming Suspension, 0.7%, 10 mL per vial, Multiple Dose Vial for Topical Use, Edge Pharma, LLC, 856 Hercules Dr., Colchester, VT 05546 NDC 05446-0572-03

by Edge Pharma, LLC

Reason: CGMP Deviations
Published: February 2, 2022
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: June 7, 2023Historical recordClass II

BLT Topical Cream, Benzocaine/Lidocaine/Tetracaine, 20%/8%/4%, 60gm per jar, Multiple Dose Container For Topical Use, Edge Pharma, LLC, 856 Hercules Dr., Colchester, VT, 05446, NDC 05446-1235-01

by Edge Pharma, LLC

Reason: CGMP Deviations
Published: February 2, 2022
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: June 7, 2023Historical recordClass II

Vancomycin HCl in 0.9% Sodium Chloride Injection, USP, 1,750mg/500mL, Single Use Bag for IV Injection (Preservative Free), 500 mL pre-filled bag, Rx Only, Edge Pharma, LLC, 856 Hercules Dr., Colchester, VT 05446 NDC 05446-1459-01

by Edge Pharma, LLC

Reason: Lack of Assurance of Sterility
Published: February 2, 2022
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: June 7, 2023Historical recordClass II

Vancomycin HCl in 0.9% Sodium Chloride Injection, 1,500 mg/500 mL, USP, Single Use Bag for IV Injection (Preservative Free), 500 mL pre-filled bag, Edge Pharma, LLC, 856 Hercules Dr., Colchester, VT 05446, NDC 05446-1458-01

by Edge Pharma, LLC

Reason: Lack of Assurance of Sterility
Published: February 2, 2022
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: June 7, 2023Historical recordClass II

Vancomycin HCl in 0.9 % Sodium Chloride Injection, USP, 1,250 mg/250 mL, Single Use Bag for IV Injection (Preservative Free), 250 mL pre-filled bag, Edge Pharma, LLC, 856 Hercules Dr., Colchester, VT 05446, NDC 05446-1456-01

by Edge Pharma, LLC

Reason: Lack of Assurance of Sterility
Published: February 2, 2022
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: June 7, 2023Historical recordClass II

Vancomycin HCl, Sterile Ophthalmic Solution for Injection, Preservative Free, 8 mg/0.8mL (10 mg/mL) (vancomycin equivalent), 0.8 mL per syringe, Single Use Syringe, For Intraocular Injection, Edge Pharma LLC, 856 Hercules Dr., Colchester, VT, 05446, NDC 05446-0736-01

by Edge Pharma, LLC

Reason: Lack of Assurance of Sterility
Published: February 2, 2022
Distribution: Nationwide

View recall →

Data last updated: October 24, 2026 ET

Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.